BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33742407)

  • 21. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
    Angelucci A; Gravina GL; Rucci N; Millimaggi D; Festuccia C; Muzi P; Teti A; Vicentini C; Bologna M
    Endocr Relat Cancer; 2006 Mar; 13(1):197-210. PubMed ID: 16601288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone.
    Dondossola E; Casarin S; Paindelli C; De-Juan-Pardo EM; Hutmacher DW; Logothetis CJ; Friedl P
    J Natl Cancer Inst; 2019 Oct; 111(10):1042-1050. PubMed ID: 30657953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
    Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
    Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.
    Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Das SK; Sarkar D; Fisher PB
    Mol Cancer Ther; 2018 Sep; 17(9):1951-1960. PubMed ID: 29934341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model.
    Chang J; Sun X; Ma X; Zhao P; Shi B; Wang Y; Han X; Yang Y
    J Vis Exp; 2022 Nov; (189):. PubMed ID: 36408984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-Time In Vivo Confocal Fluorescence Imaging of Prostate Cancer Bone-Marrow Micrometastasis Development at the Cellular Level in Nude Mice.
    Miwa S; Toneri M; Igarashi K; Yano S; Kimura H; Hayashi K; Yamamoto N; Tsuchiya H; Hoffman RM
    J Cell Biochem; 2016 Nov; 117(11):2533-7. PubMed ID: 26990763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of CRMP4, a new prostate cancer metastasis suppressor gene, inhibits tumor growth in a nude mouse intratibial injection model.
    Zhou W; Xie P; Pang M; Yang B; Fang Y; Shu T; Liu C; Wang X; Zhang L; Li S; Rong L
    Int J Oncol; 2015 Jan; 46(1):290-8. PubMed ID: 25338524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 31. Monomethyl Auristatin E Phosphate Inhibits Human Prostate Cancer Growth.
    Cunningham D; Parajuli KR; Zhang C; Wang G; Mei J; Zhang Q; Liu S; You Z
    Prostate; 2016 Nov; 76(15):1420-30. PubMed ID: 27325602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tracking Tumor Colonization in Xenograft Mouse Models Using Accelerator Mass Spectrometry.
    Hum NR; Martin KA; Malfatti MA; Haack K; Buchholz BA; Loots GG
    Sci Rep; 2018 Oct; 8(1):15013. PubMed ID: 30302019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.
    Toneri M; Miwa S; Zhang Y; Hu C; Yano S; Matsumoto Y; Bouvet M; Nakanishi H; Hoffman RM; Zhao M
    Oncotarget; 2015 Oct; 6(31):31335-43. PubMed ID: 26431498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophils are mediators of metastatic prostate cancer progression in bone.
    Costanzo-Garvey DL; Keeley T; Case AJ; Watson GF; Alsamraae M; Yu Y; Su K; Heim CE; Kielian T; Morrissey C; Frieling JS; Cook LM
    Cancer Immunol Immunother; 2020 Jun; 69(6):1113-1130. PubMed ID: 32114681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.
    Elshafae SM; Dirksen WP; Alasonyalilar-Demirer A; Breitbach J; Yuan S; Kantake N; Supsavhad W; Hassan BB; Attia Z; Alstadt LB; Rosol TJ
    Prostate; 2020 Jun; 80(9):698-714. PubMed ID: 32348616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
    Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.